Sponsoring Agency HHS
    POP 9/18/14 - 9/27/19 (5 years)


The purpose of the FDA Scientific Pharmacoepidemiologic Research Program is to establish collaborations that would provide access to a range of different types of US population-based data resources to conduct timely studies as drug safety issues of heightened interest arise. Such collaborations would allow FDA scientists the ability to leverage existing healthcare data for pharmacoepidemiology studies that may be enhanced by application of pharmacogenetic, social science, and/or pharmacologic methods to contribute to evidence-based assessments of risk management tools, special populations, and even causes of medication errors to advance the FDA regulatory science mission.

  • $0 Aggregate Dollars Obligated
  • $0 Aggregate Base & Exercised Options
  • $0 Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts